Author:
Israyelyan Anna,Shannon Edward John,Baghian Abolghasem,Kearney Michael T.,Kousoulas Konstantin G.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference50 articles.
1. Advani SJ, Chung SM, Yan SY, Gillespie GY, Markert JM, Whitley RJ, Roizman B, Weichselbaum RR (1999) Replication-competent, nonneuroinvasive genetically engineered herpes virus is highly effective in the treatment of therapy-resistant experimental human tumors. Cancer Res 59:2055–2058
2. Amato RJ, Morgan M, Rawat A (2006) Phase I/II study of thalidomide in combination with interleukin-2 in patients with metastatic renal cell carcinoma. Cancer 106:1498–1506
3. Apostolopoulos V, McKenzie IF, Lees C, Matthaei KI, Young IG (2000) A role for IL-5 in the induction of cytotoxic T lymphocytes in vivo. Eur J Immunol 30:1733–1739
4. Arrieta O, Guevara P, Tamariz J, Rembao D, Rivera E, Sotelo J (2002) Antiproliferative effect of thalidomide alone and combined with carmustine against C6 rat glioma. Int J Exp Pathol 83:99–104
5. Aslakson CJ, Miller FR (1992) Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor. Cancer Res 52:1399–1405
Cited by
14 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献